Home / Fact sheets / Population fact sheet

Country fact sheet: Cyprus

Population

- Total population: 1 170 125
- Female population: 584 133
- Male population: 585 992
The World Bank (2016)

Health Expenditure

- Total per capita (US$): 1 563.3
- Out-of-pocket (% of total expenditure on health): 43.9
World Health Organization (2015)

Human Development Index

- HDI: 0.856
- Category: Very high
UNDP Human Development Report (2015)

Geography

Life Expectancy at Birth

- Total population (years): 80.5
- Female population (years): 82.7
- Male population (years): 78.3
The World Bank (2016)

Cancer Burden

- Overall cancer incidence (rate per 100 000 persons per year): 250.8
- Overall cancer mortality (rate per 100 000 persons per year): 106.5
- Most common cancer site by incidence for females (rate per 100 000 persons per year): Breast (81.7)
- Most common cancer site by mortality for females (rate per 100 000 persons per year): Breast (16.9)
- Most common cancer site by incidence for males (rate per 100 000 persons per year): Prostate (73.9)
- Most common cancer site by mortality for males (rate per 100 000 persons per year): Lung (42.2)
- GLOBOCAN 2018 population fact sheet
GLOBOCAN (2018)

BREAST CANCER SCREENING PROGRAMME

Last updated year for qualitative data: 2016
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: 2013
Source of data: Report (EU Report 2017)

Screening protocol

Year published/updated:
Screening test used: 1
Target age (min-max) and screening interval [months] for each test: Mammography + CBE/US
(50-69 years / [24 months] )

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy: Official recommendation
Program introduction was preceded by a pilot:
Year program was initiated: 2003
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Individual
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with Population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals: From population data
Source of population data: Population register
Annual target for screening coverage:
Invitations to eligible population: For the entire target population
Method of invitation: letter
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Population-based
Current status of implementation (applicable only for population-based programmes): Roll-out completed
Cancer screening programme population based for selected populations:

Performance indicators

Target age and regional limitation if applicable: 50-69 years
Invitation coverage (%): 39.6
Examination coverage (%): 16.5
Participation rate (%): 37.7
Completeness of data related to screening results (%): 98.9
Completeness of data related to further assessment results (%): 99.9
Further assessment rate (%): 10.1
Further assessment participation rate (%): 79.0
Detection rate of CIS and invasive (x 1000): 3.46
Detection rate of invasive cancer (x 1000): 0.99
Positive predictive value of further assessment to detect CIS and invasive (%): 4.4
Proportion of total carcinomas which are CIS (%): 28.6
Benign surgical biopsy rate (x 1000):
More quantitative data (2013)



CERVICAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: 2016
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: No data available currently
Source of data: No source

Screening protocol

Year published/updated:
Screening test used:
Target age (min-max) and screening interval [months] for each test:
Triaging test used:
"screen and treat" included in the protocol:

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy:
Program introduction was preceded by a pilot:
Year program was initiated: No data submitted
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Nothing
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals:
Source of population data:
Annual target for screening coverage:
Invitations to eligible population:
Screening kit included with the invitation:
Method of invitation:
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Non population-based
Current status of implementation:
Cancer screening programme population based for selected populations/regions:

Performance indicators

Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (invitation cohort) (%):
Examination coverage (tests in the index-year) (%):
Participation rate (%):
Completeness of data related to screening test results (%):
Completeness of data related to further assessment results (%):
Colposcopy referral rate (%):
Colposcopy participation rate (%):
Detection rate of CIN2+ (x 1000):
Detection rate of CIN3+ (x 1000):
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000):
Positive Predictive Value of CIN3+ (x 1000):



COLORECTAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: No data available currently
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: No data available currently
Source of data: No source

Screening protocol

Year published/updated:
Screening test used: 1
Target age (min-max) and screening interval [months] for each test: FIT: (50-69 years / [24 months] )

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy: Official recommendation
Program introduction was preceded by a pilot:
Year program was initiated: 2013
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Individual and aggregate
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry: PBCR exists but not linked

Invitation to screening and further assessment

Method of identification of eligible individuals: From population data
Source of population data: Population register
Annual target for screening coverage:
Invitations to eligible population: For the entire target population
Method of invitation: letter
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Population-based and non population-based
Current status of implementation (applicable only for population-based programmes): Pilot
Cancer screening programme population based for selected populations:

Performance indicators

FIT gFOBT sigmoidoscopy Colonoscopy
Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (%):
Participation rate (%):
Completeness of data related to screening results (%):
Completeness of data related to information about attendance to colonoscopy assessment (%):
Completeness of data related to histology result (%):
Screen positivity (indication for follow-up colonoscopy) rate (%) :
Follow-up colonoscopy participation rate (%):
Completion rate follow-up colonoscopy (%):
Detection rate of adenomas (x 1000):
Detection rate of advanced adenomas (x 1000):
Detection rate of colorectal cancers (x 1000):
Positive Predictive Value of further assessment to detect adenomas (%):
Positive Predictive Value of further assessment to detect advanced adenomas (%):
Positive Predictive Value of further assessment to detect colorectal cancers (%):